Synthetic Biology - A Primer

Synthetic Biology - A Primer

Volumn , Issue , 2012, Pages 1-179

  Baldwin, Geoff ^a   Bayer, Travis ^a   Dickinson, Robert ^a   Ellis, Tom ^a   Freemont, Paul S ^a   Kitney, Richard I ^a   Polizzi, Karen ^a   Stan, Guy Bart ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883505754     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/P837     Document Type: Book

References (172)

1. Atkins, JF, Gesteland, RF and Cech, TR. (2011). RNA Worlds: From Life’s Origins to Diversity in Gene Regulation. Cold Spring Harbor Press, NewYork.
2. Bayer, TS and Smolke, CD. (2005). Programmable, ligand-controlled riboregulators of eukaryotic gene expression. Nat Biotechnol 23: 337-343.
3. Callura, JM, Dwyer, DJ, Isaacs, FJ, et al. (2010). Tracking, tuning, and terminating microbial physiology using synthetic riboregulators. Proc Natl Acad Sci U S A 107: 15898-15903.
4. Ellis, T, Adie, T and Baldwin, GS. (2011).DNAassembly for synthetic biology: from parts to pathways and beyond. Integrative Biology 3: 109-118.
5. Mattick, JS. (2004). RNA regulation: a new genetics? Nat Rev Genet 5: 316-323.
6. Pfleger, BF, Pitera, DJ, Smolke, CD, et al. (2006). Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes. Nat Biotechnol 24: 1027-1032.
7. Pitera, DJ, Paddon, CJ, Newman, JD, et al. (2007). Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab Eng 9: 193-207.
8. Ptashne, M. (1992). A Genetic Switch. Blackwell Scientific, Cambridge, MA.
9. Salis, HM, Mirsky, EA and Voigt, CA. (2009). Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol 27: 946-950.
10. Tucker, BJ and Breaker, RR. (2005). Riboswitches as versatile gene control elements. Curr Opin Struct Biol 15: 342-348.
11. Win, MN and Smolke, CD. (2007). RNA as a versatile and powerful platform for engineering genetic regulatory tools. Biotechnol Genet Eng Rev 24: 311-346.
12. Dorf, RC and Bishop, RH. (2008). Modern Control Systems, 11th Ed. Prentice Hall, Upper Saddle River, NJ.
13. Endy, D. (2005). Foundations for Engineering Biology. Nature 438: 449-453.
14. Franklin, GF, Powell, DJ and Workman, ML. (1997). Digital Control of Dynamic Systems, 3rd Ed. Prentice Hall, Upper Saddle River, NJ.
15. Ogata, K. (2001). Modern Control Engineering, 4th Ed. Prentice Hall, Upper Saddle River, NJ. BIOFAB initiative. An open repository for professionally characterised biological parts.Available at: http://biofab.org/ [Accessed 18 August 2011].
16. Carlson, R. (2010). Biology is Technology: The Promise, Peril, and New Business of Engineering Life. Harvard University Press, Cambridge, MA.
17. Ellis, T, Adie, T and Baldwin, GS. (2011). DNA assembly for synthetic biology: from parts to pathways and beyond. Integrative Biology 3: 109-118.
18. Endy, D. (2005). Foundations for engineering biology. Nature 438: 449-453.
19. Gulati, S, Rouilly, V, Xize, N, et al. (2009). Opportunities for microfluidic technologies in synthetic biology. J R Soc Interface 6: S493-S506.
20. Ideker, T. (2004). Systems biology 101 -What you need to know. Nat Biotechnol 22: 473-475.
21. OpenWetWare. A wiki-style online community for bioscience. Available at: http://openwetware.org [Accessed 18 August 2011].
22. Registry of Standard Biological Parts. Available at: http://partsregistry.org/Main_Page [Accessed 18 August 2011].
23. Saccharomyces Genome Database (SGD).An open online database hosting the yeast genome sequence and associated information. Available at: http://www.yeastgenome.org/ [Accessed 18 August 2011].
24. Forster, AC and Church, GM. (2006). Towards synthesis of a minimal cell. Mol Syst Biol 2(45). Available at: http://www.nature.com/msb/journal/v2/n1/pdf/msb4100090.pdf [Accessed 10 October 2011].
25. Gibson, DG, Glass, JI, Lartigue, C, et al. (2010). Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329(5987): 52-56.
26. Glass, JI, Assad-Garcia, N, Alperovich, N, et al. (2006). Essential genes of a minimal bacterium. Proc Natl Acad Sci U S A 103(2): 425-430.
27. Jewett, MC and Forster, AC. (2010). Update on designing and building minimal cells. Curr Opin Biotechnol 21(5): 697-703.
28. Kuhner, S, van Noort, V, Betts, MJ, et al. (2009). Proteome organization in a genome-reduced bacterium. Science 326(5957): 1235-1240.
29. Moya, A, Gil, R, Latorre, A, et al. (2009). Toward minimal bacterial cells: evolution vs. design. FEMS Microbiol Rev 33(1): 225-235.
30. Ochman, H and Raghavan, R. (2009). Excavating the functional landscape of bacterial cells. Science 326(5957): 1200-1201.
31. Gardner, TS, Cantor, CR and Collins, JJ. (2000). Construction of a genetic toggle switch in Escherichia coli. Nature 403: 339-342.
32. Danino, T, Mondragón-Palomino, O, Tsimring, L, et al. (2010). A synchronized quorum of genetic clocks. Nature 463: 326-330.
33. Elowitz, MB and Leibler, S. (2000). A synthetic oscillatory network of transcriptional regulators. Nature 403: 335-338.
34. Stricker, J, Cookson, S, Bennett, MR, et al. (2008).A fast robust and tunable synthetic gene oscillator. Nature 456: 516-519.
35. Tabor, JJ, Salis, HM, Simpson, ZB, et al. (2009). A synthetic genetic edge detection program. Cell 137: 1272-1281.
36. Salis, HM, Mirsky, EA and Voigt, CA (2009). Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol 27: 946-950.
37. Del Vecchio, D, Ninfa, AJ and Sontag, ED (2008). Modular cell biology: retroactivity and insulation. Mol Syst Biol 4: 161.
38. Endy, D. (2005). Foundations for engineering biology. Nature 438: 449-453.
39. Alon, U. (2007). An Introduction to Systems Biology: Design Principles of Biological Circuits. Chapman & Hall/CRC Mathematical and Computational Biology Series, Boca Raton, FL.
40. Iglesias, PA and Ingalls, BP. (2010). Control Theory and Systems Biology. MIT Press, Cambridge, MA.
41. Kitano, H. (2001). Foundations of Systems Biology. MIT Press, Cambridge, MA.
42. Wellstead, P, Bullinger, E, Kalamatianos, D, et al. (2008). The rôle of control and system theory in systems biology. Annu Rev Control 32(1): 33-47.
43. Chandran, D, Copeland, WB, Sleight, SC, et al. (2008). Mathematical modeling and synthetic biology. Drug Discov Today: Disease Models 5(4): 299-309.
44. Danino, T, Mondragón-Palomino, O, Tsimring, L, et al. (2010). A synchronized quorum of genetic clocks. Nature 463: 326-330.
45. Elowitz, MB and Leibler, S. (2000). A synthetic oscillatory network of transcriptional regulators. Nature 403: 335-338.
46. Gardner, TS, Cantor, CR and Collins, JJ. (2000). Construction of a genetic toggle switch in Escherichia coli. Nature 403: 339-342.
47. Kaznessis, YN. (2009). Multiscale models for synthetic biology. Conf Proc IEEE Eng Med Biol Soc 6408-6411.
48. Purcell, O, Savery, NJ, Grierson, CS, et al. (2010). A comparative analysis of synthetic genetic oscillators. J R Soc Interface 7(52):1503-1024.
49. Van Kampen, NG. (2007). Stochastic Processes in Physics and Chemistry. Elsevier, Amsterdam.
50. Wilkinson, DJ. (2009). Stochastic modelling for quantitative description of heterogeneous biological systems. Nat Rev Genet 10(2): 122-133.
51. Gonçalves, J and Warnick, S. (2008). Necessary and sufficient conditions for dynamical structure reconstruction of LTI networks. IEEE Trans Automat Control 53(7): 1670-1674.
52. Ljung, L. (1999). System Identification: Theory for the User, 2nd Ed. Prentice Hall, Upper Saddle River, NJ.
53. Sontag, ED. (2008). Network reconstruction based on steady-state data. Essays Biochem: Systems Biology 45: 161-176.
54. Sontag, ED, Kiyatkin, A and Kholodenko, BN. (2004). Inferring dynamic architecture of cellular networks using time series of gene expression, protein and metabolite data. Bioinformatics 20(12): 1877-1886.
55. Yuan, Y, Stan, G-B, Warnick, S, et al. (2010). Network structure reconstruction from noisy data. 49th IEEE CDC, Atlanta, Georgia.
56. Milo, R, Jorgensen, P, Moran, U, et al. (2010). BioNumbers - the database of key numbers in molecular and cell biology. Nucleic Acids Res 38(Database issue): D750-753.
57. Canton, B, Labno, A and Endy, D. (2008). Refinement and standardization of synthetic biological parts and devices. Nat Biotechnol 26(7): 787-793.
58. Burnham, KP and Anderson, DR. (2008). Model selection and multimodel inference. Technometrics 45: 18.
59. Kiparissides, A, Kucherenko, SS, Mantalaris, A, et al. (2009). Global sensitivity analysis challenges in biological systems modeling. Ind Eng Chem Res 48(15): 7168-7180.
60. Kitano, H. (2004). Biological robustness. Nat Rev Gen 5(11): 826-837.
61. Lestas, I, Vinnicombe, G and Paulsson, J. (2010). Fundamental limits on the suppression of molecular fluctuations. Nature 467: 174-178.
62. Saltelli, A. (2008). Global Sensitivity Analysis: The Primer. JohnWiley, Chichester.
63. Saltelli, A, Ratto, M, Tarantola, S, et al. (2005). Sensitivity analysis for chemical models. Chem Rev 105(7): 2811-2827.
64. Zhou, K, Doyle, JC and Glover, K. (1995). Robust and Optimal Control. Prentice Hall, Upper Saddle River, NJ.
65. Del Vecchio, D and Murray, R. (2010). Biomolecular Feedback Systems. Available at: http://www.cds.caltech.edu/∼murray/amwiki/index.php? [Accessed 6 September 2011].
66. Dhooge, A, Govaerts, W, Yu, A, et al. (2003). MATCONT: a MATLAB package for numerical bifurcation analysis of ODEs. ACM Trans Math Software 29(2): 141-164.
67. Ermentrout, B. (2003). Simulating, analyzing, and animating dynamical systems: a guide to XPPAUT for researchers and students. Appl Mech Rev 56(4): B53-B53.
68. Geva-Zatorsky, N, Rosenfeld, N, Itzkovitz, S, et al. (2006). Oscillations and variability in the p53 system. Mol Syst Biol 2: 20060033. Available at: http://www.nature.com/msb/journal/v2/n1/ pdf/msb4100068.pdf [Accessed 5 November 2011].
69. Heinemann, M and Panke, S. (2006). Synthetic biology - putting engineering into biology. Bioinformatics 22(22): 2790-2799.
70. Lestas, I, Vinnicombe, G and Paulsson, J. (2010). Fundamental limits on the suppression of molecular fluctuations. Nature 467: 174-178.
71. Meinhardt, H and de Boer, PA. (2001). Pattern formation in Escherichia coli: a model for the poletopole oscillations of Min proteins and the localization of the division site. Proc Natl Acad Sci U S A 98(25): 14202-14207.
72. Phillips, A and Cardelli, L. (2009). A programming language for composable DNA circuits. J R Soc Interface 6 Suppl 4: S419-436.
73. Purnick, PEM and Weiss, R. (2009). The second wave of synthetic biology: from modules to systems. Nat Rev Mol Cell Bio 10(6): 410-422.
74. Rizk, A, Batt, G, Fages, F, et al. (2009).A general computational method for robustness analysis with applications to synthetic gene networks. Bioinformatics 25(12): 169-178.
75. Rodriguez-Fernandez, M and Banga, JR. (2010). SensSB: a software toolbox for the development and sensitivity analysis of systems biology models. Bioinformatics 26(13): 1675-1676.
76. Salis, HM, Mirsky, EA and Voigt, CA. (2009). Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol 27(10): 946-950.
77. Stricker, J, Cookson, S, Bennett, MR, et al. (2008).A fast, robust and tunable synthetic gene oscillator. Nature 456: 516-519.
78. Strogatz, S. (1994). Nonlinear Dynamics and Chaos: with applications to physics, biology, chemistry, and engineering. Perseus Books, NewYork.
79. Thattai, M and van Oudenaarden, A. (2001). Intrinsic noise in gene regulatory networks. Proc Natl Acad Sci U S A 98(15): 8614-8619.
80. Turk, G. (1991). Generating textures on arbitrary surfaces using reaction-diffusion. Siggraph 91 Conf Proc 25: 289-298.
81. Zheng, Y and Sriram, G. (2010). Mathematical modeling: bridging the gap between concept and realization in synthetic biology. J Biomed Biotechnol. Available at: http://downloads.hindawi. com/journals/jbb/2010/541609.pdf [Accessed 7 November 2011].
82. Zi, Z, Zheng, Y, Rundell, AE, et al. (2008). SBML-SAT: a systems biology markup language (SBML) based sensitivity analysis tool. Bioinformatics 9: 342. Available at: http://www.biomedcentral. com/content/pdf/1471-2105-9-342.pdf [Accessed 7 November 2011].
83. Alper, H and Stephanopoulos, G. (2009). Engineering for biofuels: exploiting innate microbial capacity or importing biosynthetic potential? Nat Rev Microbiol 7(10): 715-723.
84. Anderson, JC, Clarke, EJ, Arkin, AP, et al. (2006). Environmentally controlled invasion of cancer cells by engineered bacteria. J Mol Biol 355(4): 619-627.
85. Bayer, TS. (2010). Transforming biosynthesis into an information science. Nat Chem Biol 6(12): 859-861.
86. BCC Research: Synthetic Biology: Emerging Global Markets. Available at: http://www. bccresearch.com/report/BIO066A.html [Accessed 6 September 2011].
87. Chang, MCY, Eachus, RA, Trieu, W, et al. (2007). Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol 3(5): 274-277.
88. Chang, MCY and Keasling, JD. (2006). Production of isoprenoid pharmaceuticals by engineered microbes. Nat Chem Biol 2(12): 674-681.
89. Ferrer-Miralles, N, Domingo-Espin, J, Corchero, JL, et al. (2009). Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 8(17). Available at: http://www.microbialcellfactories.com/ content/pdf/1475-2859-8-17.pdf [Accessed 7 November 2011].
90. Keasling, JD. (2010). Manufacturing molecules through metabolic engineering. Science 330: 1355-1358.
91. Lee, SK, Chou, H, Ham, TS, et al. (2008). Metabolic engineering of microorganisms for biofuels production: from bugs to synthetic biology to fuels. Curr Opin Biotechnol 19(6): 556-563.
92. Levskaya, A, Weiner, OD, Lim, WA, et al. (2009). Spatiotemporal control of cell signalling using a light-switchable protein interaction. Nature 461: 997-1001.
93. Prather, KLJ and Martin, CH. (2008). De novo biosynthetic pathways: rational design of microbial chemical factories. Curr Opin Biotechnol 19(5): 468-474.
94. Ro, DK, Paradise, EM, Ouellet, M, et al. (2006). Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440: 940-943.
95. Rude, MA and Schirmer, A. (2009). New microbial fuels: a biotech perspective. Curr Opin Microbiol 12(3): 274-281.
96. Steen, EJ, Kang, YS, Bokinsky, G, et al. (2010). Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature 463: 559-U182.
97. Tabor, JJ, Levskaya, A and Voigt, CA. (2011). Multichromatic control of gene expression in Escherichia coli. J Mol Biol 405(2): 315-324.
98. Topp, S and Gallivan, JP. (2007). Guiding bacteria with small molecules and RNA. J Am Chem Soc 129(21): 6807-6811.
99. van der Meer, JR and Belkin, S. (2010). Where microbiology meets microengineering: design and applications of reporter bacteria. Nat Rev Microbiol 8(7): 511-522.
100. Verpoorte, R, van der Heijden, R and Memelink, J. (2000). Engineering the plant cell factory for secondary metabolite production. Transgenic Res 9(4-5): 323-343.
101. Widmaier, DM, Tullman-Ercek, D, Mirsky, EA, et al. (2009). Engineering the Salmonella type III secretion system to export spider silk monomers. Mol Syst Biol 5. Available at: http://www. nature.com/msb/journal/v5/n1/pdf/msb200962.pdf [Accessed 5 November 2011]. Learn About iGEM. Available at: http://ung.igem.org/IGEM/Learn_About [Accessed 6 September 2011].
102. Levaskya, A, Chevalier, A, Tabor, J, et al. (2005). Synthetic biology: engineering Escherichia coli to see light. Nature 438: 441-442.
103. Lou, C, Liu, X, Ni, M, et al. (2010). Synthesizing a novel genetic sequential logic circuit: a pushonpush-off switch. Mol Syst Biol 6: 350. Available at: http://www.nature.com/msb/journal/ v6/n1/full/msb20102.html [Accessed 7 November 2011].
104. OpenWetWare. A wiki-style online community for bioscience. Available at: http://openwetware.org [Accessed 6 September 2011].
105. Registry of Standard Biological Parts. Available at: http://partsregistry.org/Main_Page [Accessed 6 September 2011].
106. Tabor, JJ, Salis, HM, Simpson, ZB, et al. (2009). A synthetic genetic edge detection program. Cell 137(7): 1272-1281.
107. Ball, P. (2010). Making life: A comment on ‘Playing God in Frankenstein’s footsteps: Synthetic biology and the meaning of life’ by Henk van den Belt (2009). Nanoethics 4: 129-132.
108. Beatty, D. (1950). ‘Sometimes we fail: Whenever we fail to be of help we must look into ourselves. Pastoral Psychol 1(7): 16-19.
109. BioBricks Foundation. Our Goals. Available at: http://biobricks.org/Our_Goals.php [Accessed 6 September 2011].
110. Bio-Economic Research Associates (Bio-ERA). (2007). Genome Synthesis and Design Futures: Implications for the US Economy. Bio-ERA, Cambridge, MA.
111. BIOFAB. About the biofab. Available at: http://www.biofab.org/about [Accessed 6 September 2011].
112. Canguilhem, G. (2009). Knowledge of Life. Fordham University Press, NewYork.
113. Carey, J. (2007). On the brink of artificial life. Business Week. 25 June: 40.
114. Carlson, R. (2009). The changing economics of DNA synthesis. Nat Biotechnol 27: 1091-1094.
115. Cello, J, Paul, AV and Wimmer, E. (2002). Chemical synthesis of poliovirus cDNA: Generation of infectious virus in the absence of natural template. Science 297: 1016-1018.
116. Central Intelligence Agency. (2003). The Darker Bioweapons Future. Unclassified report, released 3 November 2003.
117. Church, G. (2005). Let us go forth and safely multiply. Nature 438: 423.
118. Dabrock, P. (2009). Playing God? Synthetic biology as a theological and ethical challenge. Syst Synth Biol 3: 47-54.
119. Davies, S, Kearnes, M and Macnaghten, P. (2009). All things weird and scary: Nanotechnology, theology and cultural resources. Culture and Religion 10(2): 201-220.
120. Department of Energy, USA. (2010). Secretary Chu announces nearly $80 million investment for advanced biofuels research and fueling infrastructure. Press release, 13 January 2010.
121. Deplazes, A and Huppenbauer, M. (2009). Synthetic organisms and living machines: Positioning the products of synthetic biology at the borderline between living and non-living matter. Syst Synth Biol 3: 55-63.
122. Doornbosch, R and Steenblik, R. (2007). Biofuels: Is the cure worse than the disease? OECD Round Table on Sustainable Development. 11-12 September 2007, OECD, Paris.
123. Drees, W. (2002). ‘Playing God?Yes!’ Religion in the light of technology. Zygon: Journal of Religion and Science 37: 643-654.
124. Editorial (2010). Artemisinin export slumped, the industry in danger. Pharmaceutical Economic News (China). 20 January.
125. ETC Group. (2007). Extreme Genetic Engineering -An Introduction to Synthetic Biology, January. Available at: http://www.etcgroup.org/en/node/602 [Accessed 6 September 2011].
126. ETC Group. (2008). Commodifying Nature’s Last Straw? Extreme Genetic Engineering and the Post-Petroleum Sugar Economy, October. Available at: http://www.etcgroup.org/en/node/703 [Accessed 6 September 2011].
127. EuropaBio. (2008). EuropaBio Fact Sheet: Biofuels and Land Use, March. EuropaBio, Brussels.
128. Ferber, D. (2004). Synthetic biology. Time for a synthetic biology Asilomar? Science 303: 159.
129. Fletcher, J. (1960). The patient’s right to die. Harper’s Magazine. October: 139-143.
130. Gerstein, R. (1960). A prosecutor looks at capital punishment. J Crim Law Crimnol 51: 252-256.
131. Goodfield, J. (1977). Playing God: Genetic Engineering and the Manipulation of Life. Random House, NewYork.
132. Grey, W. (1998). ‘Playing God’ in Chadwick, R. (Ed.). The Concise Encyclopaedia of the Ethics of New Technologies. Academic Press, San Diego, 335-339.
133. Haeckel, E. (1866). Generelle Morphologie der Organismen (General Morphology of the Organisms). Reimer, Berlin.
134. Harken, D. (1968). One surgeon looks at human heart transplantation. Dis Chest 54(4): 349-352.
135. Heller, M. (1998). The tragedy of the anticommons: Property in the transition from Marx to markets. Harvard Law Rev 111: 621-688.
136. Heller, M and Eisenberg, R. (1998).Can patents deter innovation? The anticommons in biomedical research. Science 289: 698-701.
137. Hope, J. (2008). Biobazaar: The Open Source Revolution and Biotechnology. Harvard University Press, Cambridge, MA.
138. iGEM. (2010). About. Available at: http://2010.igem.org/About [Accessed 6 September 2011].
139. Institute for OneWorld Health. (2010). The drug, produced by genetically engineered bacteria, is much cheaper than the plant-derived drug available today. Press release, 7 July 2010.
140. Kirkham, G. (2006). ‘Playing God’ and ‘vexing nature’: A cultural perspective. Environ Value 15: 173-195.
141. Kline, C. (1963). The potential significance of sperm banks. Advances in Sex Research 1: 123-127.
142. Kumar, S and Rai, A. (2007). Synthetic biology: The intellectual property puzzle. Tex Law Rev 85: 1744-1768.
143. Leduc, S. (1911). The Mechanism of Life.William Heinemann, London.
144. Lentzos, F, Bennett, G, Boeke, J, et al. (2008).Visions and challenges in redesigning life. BioSocieties 3(3): 311-323.
145. Levskaya, A, Chevalier, A, Tabor, J, et al. (2005). Engineering Escherichia coli to see light. Nature 438: 441-442.
146. Loeb, J. (1912). The Mechanistic Conception of Life. University of Chicago Press, Chicago.
147. McGregor, D. (1957). An uneasy look at performance appraisal. Harvard Bus Rev 35: 89-94.
148. National Research Council. (2004). Biotechnology in an Age of Terrorism. National Academies Press, Washington DC.
149. National Research Council. (2009). A Survey of Attitudes and Actions on Dual Use Research in the Life Sciences. National Academies Press, Washington DC.
150. New and Emerging Science and Technology. (2005). Synthetic Biology: Applying Engineering to Biology. Report of a NEST High-Level Expert Group. European Commission, Luxembourg. OpenWetWare. A wiki-style online community for bioscience. Available at: http://openwetware.org/ wiki [Accessed 6 September 2011].
151. Peters, T. (2003). Playing God? Genetic Determinism and Human Freedom. Routledge, NewYork.
152. Peters, T. (2006). ‘Contributions from practical theology and ethics’ in Clayton, P and Simpson, Z. (Eds). The Oxford Handbook of Religion and Science. Oxford University Press, Oxford, 372-387.
153. Rai, A and Boyle, J. (2007). Synthetic biology: Caught between property rights, the public domain, and the commons. PLoS Biology 5: 389-393.
154. Registry of Standard Biological Parts. Available at: http://partsregistry.org [Accessed 6 September 2011].
155. Schmidt, M, Torgersen, H, Ganguli-Mitra, A, et al.(2008). SYNBIOSAFE e-conference: Online community discussion on the societal aspects of synthetic biology. Syst Synth Biol 2: 7-17.
156. Shannon, E. (1956). Emma: Character and construction. PMLA 71(4): 637-650.
157. Skinner, M. (1939). Playing God. Engl J 28(6): 471.
158. Smil, V. (2003). Energy at the Crossroads. MIT Press, Cambridge, MA.
159. Smith, GL and Davison, N. (2010). Assessing the spectrum of biological risks. Bull Atomic Scientists 66(1) 1-11.
160. SPB. (2006). Criteria for Sustainable Biomass Production. 14 July 2006. Project Group for Sustainable Production of Biomass.
161. Su, K. (2010). Blind expansion on Artemisinin. Pharmaceutical Economics News (China). 30 March.
162. Tollefson, J. (2008). Energy: Not your father’s biofuels. Nature 451: 880-883.
163. Tucker, JB and Zilinskas, RA. (2006). The promise and perils of synthetic biology. The New Atlantis 12: 25-45.
164. Tumpey, TM, Basler, CF, Aguilar, PV, et al. (2005). Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310: 77-80.
165. van den Belt, H. (2009). Playing God in Frankenstein’s footsteps: Synthetic biology and the meaning of life. Nanoethics 3: 257-268.
166. Vogel, KM. (2008). Framing biosecurity: An alternative to the biotech revolution model? Science and Public Policy 35: 1.
167. Wellhausen, R and Mukunda, G. (2009). Aspects of the political economy of development of synthetic biology. Syst Synth Biol 3: 115-123.
168. World Health Organization. (2010). Drug resistance could set back malaria control success. Press release, 25 February 2010. World Intellectual Property Organization: Available at: http://www.wipo.int/portal/index.html.en [Accessed 6 September 2011].
169. World Intellectual Property Organization (undated). Frequently Asked Questions. Available at: http://www.wipo.int/patentscope/en/patents_faq.html#patent [Accessed 6 September 2011].
170. World Intellectual Property Organization (undated). Understanding Copyright and Related Rights. Available at: http://www.wipo.int/freepublications/en/intproperty/909/wipo_pub_909.html [Accessed 6 September 2011].
171. Zhou, EY. (2006). Chinese biogenerics and protection of IP: Large market potential and solid foundation set the stage. Genetic Eng Biotechn 26(15): 56-60.
172. Zimmer, C. (2008). Artificial life? Old news.Wired.com.Available at: http://www.wired.com/science/ discoveries/commentary/dissection/2008/01/dissection_0125 [Accessed 25 January 2008].